AC Immune SA Receivables

AC Immune SA (ACIU) currently reports a receivables of $4.1M as of September 2026. That compares with $400K in the prior-year period — up 910.7% year over year. Use the charts on this page to explore AC Immune SA's receivables history and peer comparisons.

AC Immune SA's receivables increased from $400K to $4.1M — a 910.7% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AC Immune SA reported $4.1M in receivables as of September 2026. That compares with $400K in the prior-year period — up 910.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $4.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AC Immune SA, and consider following ACIU for alerts when major investors trade the stock.

AC Immune SA is classified in the Healthcare sector. On receivables, it currently shows $4.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACIU with unrelated industries.